Researchers have successfully grown stem cells from children with a devastating neurological disease to help explain how different genetic backgrounds can cause common symptoms.
You are here
Coverage of the latest news and updates from the field of stem cells.
Photodynamic detection and therapy has recently emerged as a promising approach for diagnosing and treating cancer.
Researchers have generated the first immortalized cell lines that allow more efficient manufacture of red blood cells. The team, from the University of Bristol and NHS Blood and Transplant, were able to manufacture red blood cells in a more efficient scale than was previously possible.
Researchers from the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg and an international team have identified an ingenious mechanism by which the body orchestrates the regeneration of red and white blood cells from progenitor cells.
Using a technique that avoids the use of high-dose chemotherapy and radiation in preparation for a stem cell transplant, physicians at the University of Illinois Hospital & Health Sciences System have documented the first cure of an adult patient with congenital dyserythropoietic anemia.
New clinical trial results show that stem cells can restore sufficient erectile function to allow previously impotent men to have spontaneous intercourse. This is the first time that stem cell therapy has produced patients who recovered sufficient erectile function to enable intercourse.
Cedars-Sinai investigators have identified a stem cell-regulating gene that affects tumor growth in patients with brain cancer and can strongly influence survival rates of patients.
Mesoblast Ltd., a producer of cell-based therapies based in Melbourne, Australia, recently released the results of two studies that it says show promise for its stem cell products in treating rheumatoid arthritis and chronic lower back pain.
Israeli biotechnology company Kadimastem has been granted a patent from the United States Patent and Trademark Office for its technology in the field of cell-based treatment for diseases of the nervous system. The U.S. patent joins additional patents granted in Israel and
Chronic pain from nerve injury is common and often debilitating. Current treatment options for neuropathic pain include physical, cognitive, behavioral, pharmacological, interventional and surgical therapies.